ev d68 strains us mo (ATCC)
Structured Review
Ev D68 Strains Us Mo, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterovirus+d68+ev+d68+strains+us+mo/Enterovirus+D68+%3BStrain%3A+US%2FMO%2F14-18947/pmc12593654-247-1-23
Average 93 stars, based on 4 article reviews
Images
Related Articles
Binding Assay:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Standard Deviation:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Activity Assay:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Plaque Assay:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Incubation:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Concentration Assay:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Positive Control:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Recombinant:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Ligand Binding Assay:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Sequencing:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Mutagenesis:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Control:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Infection:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Virus:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Staining:Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Article Snippet: Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cellswere cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. Enterovirus D68 (EV-D68) strains US/MO/14-18947, US/KY/1418953, US/MO/14-18949, US/IL/14-18952, and US/IL/14-18956 (ATCC); Coxsackievirus B3 (CVB3) Nancy strain (VR-30); Enterovirus A71 (EVA71) Tainan/4643/1998 (BEI Resources, NR-471); Coxsackievirus A6 (CVA6, VR-1801); and human rhinovirus 16 (RV16, VR-283) were sourced fromATCC or BEI Resources.. Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement.Coxsackievirus A16 (CVA16) and poliovirus type 1 were provided by Dr. William Nix (CDC) under a material transfer agreement. Article Title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis Article Snippet: Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.Cells were cultured at 37 °C in a humidified incubator with 5% CO2 and routinely screened to confirm the absence of mycoplasma contamination.. |
